Clinical Utility of Interferon Gamma Assay in the Diagnosis of Tuberculosis

References

1. ↵
   Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003; 362: 887–99.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Dye C. Global epidemiology of tuberculosis. Lancet 2006; 367: 938–40.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   Huebner RE, Castro KG. The changing face of tuberculosis. Annu Rev Med 1995; 46: 47–55.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   Murray JF. A century of tuberculosis. Am J Respir Crit Care Med 2004; 169: 1181–6.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   Lee E, Holzman RS. Evolution and current use of the tuberculin test. Clin Infect Dis 2002; 34: 365–70.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004; 170: 65–9.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   Chaparas SD, Vandiviere HM, Melvin I, Koch G, Becker C. Tuberculin test. Variability with the Mantoux procedure. Am Rev Respir Dis 1985; 132: 175–7.

   OpenUrlPubMedWeb of Science
8. ↵
   Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Morb Mortal Wkly Rep 2005; 54: 49–55.

   OpenUrlPubMed
9. ↵
   Ferrara G, Losi M, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367: 1328–34.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Meier T, Eulenbruch HP, Wrighton-Smith P, Enders G, Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 2005; 24: 529–36.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    Barnes PF. Diagnosing latent tuberculosis infection: turning glitter to gold. Am J Respir Crit Care Med 2004; 170: 5–6.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    Pai M, Riley LW, Colford Jr JM. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4: 761–76.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    Orme IM, Roberts AD, Griffin JP, Abrams JS. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993; 151: 518–25.

    OpenUrlAbstract
14. ↵
    Goletti D, Vincenti D, Carrara S, et al. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol 2005; 12: 1311–6.

    OpenUrlCrossRefPubMed
15. ↵
    Brock I, Munk ME, Kok-Jensen A, Andersen P. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001; 5: 462–7.

    OpenUrlPubMedWeb of Science
16. ↵
    Cellestis Limited. QuantiFERON-TB Gold (in-tube method) [package insert]. Available at http://www.cellestis.com/IRM/Company/ShowPage.aspx?CPID=1023. Accessed 29 August 2007.
17. ↵
    Ferrara G, Losi M, Meacci M, et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005; 172: 631–65.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res 2006; 7: 77.

    OpenUrlCrossRefPubMed
19. Brock I, Weldingh K, Leyten EM, Arend SM, Ravn P, Andersen P. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol 2004; 42: 2379–87.

    OpenUrlAbstract/FREE Full Text
20. ↵
    Kang YA, Lee HW, Yoon HI, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005; 293: 2756–61.

    OpenUrlCrossRefPubMedWeb of Science
21. Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006; 174: 349–55.

    OpenUrlCrossRefPubMedWeb of Science
22. ↵
    Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res 2006; 7: 56.

    OpenUrlCrossRefPubMed
23. ↵
    Arend SM, van Meijgaarden KE, de Boer K, et al. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis 2002; 186: 1797–807.

    OpenUrlAbstract/FREE Full Text
24. ↵
    Geluk A, van Meijgaarden KE, Franken KL, et al. Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis. Infect Immun 2002; 70: 2544–8.

    OpenUrlAbstract/FREE Full Text
25. ↵
    Taylor JP, Vitek I, Enriquez V, Smedley JW. A continuing focus of Hansen's disease in Texas. Am J Trop Med Hyg 1999; 60: 449–52.

    OpenUrlAbstract
26. ↵
    Van Pittius NCG, Gamieldien J, Hide W, Brown GD, Siezen RJ, Beyers AD. The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria. Genome Biol 2001; 2: 44.

    OpenUrlPubMed
27. ↵
    Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286: 1740–7.

    OpenUrlCrossRefPubMedWeb of Science
28. ↵
    Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170: 59–64.

    OpenUrlCrossRefPubMedWeb of Science
29. ↵
    Ravn P, Munk ME, Andersen AB, et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 2005; 12: 491–6.

    OpenUrlCrossRefPubMed
30. ↵
    Lalvani A. Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin Infect Dis 2004; 38: 757–9.

    OpenUrlFREE Full Text
31. ↵
    Pai M, Joshi R, Dogra S, et al. Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol 2006; 1: 7.

    OpenUrlCrossRefPubMed
32. ↵
    Hill PC, Brookes RH, Fox A, et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 2004; 38: 966–73.

    OpenUrlAbstract/FREE Full Text
33. ↵
    Streeton JA, Desem N, Jones SL. Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int J Tuberc Lung Dis 1998; 2: 443–50.

    OpenUrlPubMedWeb of Science
34. ↵
    Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2006; 361: 1168–73.

    OpenUrl
35. ↵
    Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009–21.

    OpenUrlCrossRefPubMedWeb of Science
36. ↵
    Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575–80.

    OpenUrlCrossRefPubMedWeb of Science
37. ↵
    Pai M, Lewinsohn DM. Interferon-gamma assays for tuberculosis: is anergy the Achilles’ heel? Am J Respir Crit Care Med 2005; 172: 519–21.

    OpenUrlCrossRefPubMedWeb of Science
38. ↵
    Sutherland R, Yang H, Scriba TJ, et al. Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART. AIDS 2006; 20: 821–9.

    OpenUrlPubMedWeb of Science
39. ↵
    Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002; 16: 2285–93.

    OpenUrlCrossRefPubMedWeb of Science
40. ↵
    Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis 2006; 6: 47.

    OpenUrlCrossRefPubMed
41. ↵
    Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2006; 174: 736–42.

    OpenUrlCrossRefPubMedWeb of Science
42. ↵
    Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004; 364: 2196–203.

    OpenUrlCrossRefPubMedWeb of Science
43. ↵
    Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005; 293: 2746–55.

    OpenUrlCrossRefPubMedWeb of Science
44. ↵
    Aiken AM, Hill PC, Fox A, et al. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 2006; 30: 66.

    OpenUrl